Critical role for CCAAT/enhancer-binding protein β in immune complex-induced acute lung injury

Journal of Immunology

Volumn 189, Issue 3, 2012, Pages 1480-1490

  Yan, Chunguang ^a,b   Wu, Min ^b   Cao, Jay ^c   Tang, Huifang ^a   Zhu, Mei ^d   Johnson, Peter F ^e   Gao, Hongwei ^a  

^a BRIGHAM AND WOMEN S HOSPITAL   (United States)

^b UNIVERSITY OF NORTH DAKOTA   (United States)

^c GRAND FORKS HUMAN NUTRITION RESEARCH CENTER   (United States)

^d HARVARD MEDICAL SCHOOL   (United States)

^e NATIONAL CANCER INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA CHEMOKINE; BETA CHEMOKINE; CCAAT ENHANCER BINDING PROTEIN BETA; CCAAT ENHANCER BINDING PROTEIN DELTA; CHEMOKINE; CXCL3 CHEMOKINE; IMMUNOGLOBULIN G; INTERCELLULAR ADHESION MOLECULE 1; INTERLEUKIN 6; KERATINOCYTE CELL DERIVED CHEMOKINE; MACROPHAGE INFLAMMATORY PROTEIN 1ALPHA; MESSENGER RNA; MYELOPEROXIDASE; SMALL INTERFERING RNA; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG;

ACUTE LUNG INJURY; ANIMAL CELL; ANIMAL TISSUE; ARTICLE; BLOOD VESSEL PERMEABILITY; CONTROLLED STUDY; CYTOKINE RELEASE; ENZYME ACTIVITY; GENE CONTROL; GENE DELETION; IMMUNE COMPLEX DEPOSITION; INFLAMMATION; LEUKOCYTE COUNT; LUNG ALVEOLUS MACROPHAGE; LUNG BLOOD VESSEL; LUNG LAVAGE; MALE; MEDIATOR RELEASE; MOUSE; MOUSE MUTANT; MOUSE STRAIN; NEUTROPHIL; NONHUMAN; PHENOTYPE; PNEUMONIA; PRIORITY JOURNAL; PROTEIN DEFICIENCY; PROTEIN FUNCTION;

ACUTE LUNG INJURY; ANIMALS; ANTIGEN-ANTIBODY COMPLEX; CCAAT-ENHANCER-BINDING PROTEIN-BETA; CCAAT-ENHANCER-BINDING PROTEIN-DELTA; CELL LINE; DISEASE MODELS, ANIMAL; IMMUNOGLOBULIN G; INFLAMMATION MEDIATORS; MACROPHAGES, ALVEOLAR; MALE; MICE; MICE, 129 STRAIN; MICE, INBRED C57BL; MICE, KNOCKOUT;

EID: 84864149334     PISSN: 00221767     EISSN: 15506606     Source Type: Journal    
DOI: 10.4049/jimmunol.1200877     Document Type: Article

References (43)

1. Lekstrom-Himes, J., and K. G. Xanthopoulos. 1998. Biological role of the CCAAT/enhancer-binding protein family of transcription factors. J. Biol. Chem. 273: 28545-28548.
2. Poli, V. 1998. The role of C/EBP isoforms in the control of inflammatory and native immunity functions. J. Biol. Chem. 273: 29279-29282.
3. Gorgoni, B., D. Maritano, P. Marthyn, M. Righi, and V. Poli. 2002. C/EBP beta gene inactivation causes both impaired and enhanced gene expression and inverse regulation of IL-12 p40 and p35 mRNAs in macrophages. J. Immunol. 168: 4055-4062.
4. Uematsu, S., M. Matsumoto, K. Takeda, and S. Akira. 2002. Lipopolysaccharide-dependent prostaglandin E(2) production is regulated by the glutathione-dependent prostaglandin E(2) synthase gene induced by the Toll-like receptor 4/MyD88/NF-IL6 pathway. J. Immunol. 168: 5811-5816.
5. Hu, H. M., M. Baer, S. C. Williams, P. F. Johnson, and R. C. Schwartz. 1998. Redundancy of C/EBP alpha, -beta, and -delta in supporting the lipopolysaccharide-induced transcription of IL-6 and monocyte chemoattractant protein-1. J. Immunol. 160: 2334-2342.
6. Caivano, M., B. Gorgoni, P. Cohen, and V. Poli. 2001. The induction of cyclooxygenase-2 mRNA in macrophages is biphasic and requires both CCAAT enhancer-binding protein beta (C/EBP beta ) and C/EBP delta transcription factors. J. Biol. Chem. 276: 48693-48701.
7. Albina, J. E., E. J. Mahoney, J. M. Daley, D. E. Wesche, S. M. Morris, Jr., and J. S. Reichner. 2005. Macrophage arginase regulation by CCAAT/enhancer-binding protein beta. Shock 23: 168-172.
8. Serio, K. J., K. V. Reddy, and T. D. Bigby. 2005. Lipopolysaccharide induces 5- lipoxygenase-activating protein gene expression in THP-1 cells via a NF-kappaB and C/EBP-mediated mechanism. Am. J. Physiol. Cell Physiol. 288: C1125-C1133.
9. Cassel, T. N., and M. Nord. 2003. C/EBP transcription factors in the lung epithelium. Am. J. Physiol. Lung Cell. Mol. Physiol. 285: L773-L781.
10. Sugahara, K., T. Sadohara, M. Sugita, K. Iyama, and M. Takiguchi. 1999. Differential expression of CCAAT enhancer binding protein family in rat alveolar epithelial cell proliferation and in acute lung injury. Cell Tissue Res. 297: 261-270.
11. Didon, L., J. L. Barton, A. B. Roos, G. J. Gaschler, C. M. Bauer, T. Berg, M. R. Stampfli, and M. Nord. 2011. Lung epithelial C/EBPs is necessary for the integrity of inflammatory responses to cigarette smoke. Am. J. Respir. Crit. Care Med. 184: 233-242.
12. Hu, B., M. R. Ullenbruch, H. Jin, M. Gharaee-Kermani, and S. H. Phan. 2007. An essential role for CCAAT/enhancer binding protein beta in bleomycininduced pulmonary fibrosis. J. Pathol. 211: 455-462.
13. Gao, H., L. M. Hoesel, R. F. Guo, N. J. Rancilio, J. V. Sarma, and P. A. Ward. 2006. Adenoviral-mediated overexpression of SOCS3 enhances IgG immune complex-induced acute lung injury. J. Immunol. 177: 612-620.
14. Ward, P. A. 1996. Role of complement, chemokines, and regulatory cytokines in acute lung injury. Ann. N. Y. Acad. Sci. 796: 104-112.
15. Guo, R. F., A. B. Lentsch, J. V. Sarma, L. Sun, N. C. Riedemann, S. D. McClintock, S. R. McGuire, N. Van Rooijen, and P. A. Ward. 2002. Activator protein-1 activation in acute lung injury. Am. J. Pathol. 161: 275-282.
16. Lentsch, A. B., B. J. Czermak, N. M. Bless, and P. A. Ward. 1998. NF-kappaB activation during IgG immune complex-induced lung injury: requirements for TNF-alpha and IL-1beta but not complement. Am. J. Pathol. 152: 1327-1336.
17. Tang, H., C. Yan, J. Cao, J. V. Sarma, E. B. Haura, M. Wu, and H. Gao. 2011. An essential role for Stat3 in regulating IgG immune complex-induced pulmonary inflammation. FASEB J. 25: 4292-4300.
18. Zhang, K., W. Guo, Y. Yang, and J. Wu. 2011. JAK2/STAT3 pathway is involved in the early stage of adipogenesis through regulating C/EBPb transcription. J. Cell. Biochem. 112: 488-497.
19. Cantwell, C. A., E. Sterneck, and P. F. Johnson. 1998. Interleukin-6-specific activation of the C/EBPdelta gene in hepatocytes is mediated by Stat3 and Sp1. Mol. Cell. Biol. 18: 2108-2117.
20. Sterneck, E., L. Tessarollo, and P. F. Johnson. 1997. An essential role for C/ EBPbeta in female reproduction. Genes Dev. 11: 2153-2162.
21. Sterneck, E., R. Paylor, V. Jackson-Lewis, M. Libbey, S. Przedborski, L. Tessarollo, J. N. Crawley, and P. F. Johnson. 1998. Selectively enhanced contextual fear conditioning in mice lacking the transcriptional regulator CCAAT/enhancer binding protein delta. Proc. Natl. Acad. Sci. USA 95: 10908-10913.
22. Van Rooijen, N., and A. Sanders. 1994. Liposome mediated depletion of macrophages: mechanism of action, preparation of liposomes and applications. J. Immunol. Methods 174: 83-93.
23. Gao, H., S. Parkin, P. F. Johnson, and R. C. Schwartz. 2002. C/EBP gamma has a stimulatory role on the IL-6 and IL-8 promoters. J. Biol. Chem. 277: 38827-38837.
24. Baer, M. R. 1998. Assessment of minimal residual disease in patients with acute leukemia. Curr. Opin. Oncol. 10: 17-22.
25. Descombes, P., and U. Schibler. 1991. A liver-enriched transcriptional activator protein, LAP, and a transcriptional inhibitory protein, LIP, are translated from the same mRNA. Cell 67: 569-579.
26. Gao, H., T. Neff, and P. A. Ward. 2006. Regulation of lung inflammation in the model of IgG immune-complex injury. Annu. Rev. Pathol. 1: 215-242.
27. Lentsch, A. B., B. J. Czermak, N. M. Bless, N. Van Rooijen, and P. A. Ward. 1999. Essential role of alveolar macrophages in intrapulmonary activation of NF-kappaB. Am. J. Respir. Cell Mol. Biol. 20: 692-698.
28. Mulligan, M. S., G. P. Wilson, R. F. Todd, C. W. Smith, D. C. Anderson, J. Varani, T. B. Issekutz, M. Miyasaka, T. Tamatani, et al. 1993. Role of beta 1, beta 2 integrins and ICAM-1 in lung injury after deposition of IgG and IgA immune complexes. J. Immunol. 150: 2407-2417.
29. Schmal, H., B. J. Czermak, A. B. Lentsch, N. M. Bless, B. Beck-Schimmer, H. P. Friedl, and P. A. Ward. 1998. Soluble ICAM-1 activates lung macrophages and enhances lung injury. J. Immunol. 161: 3685-3693.
30. Lentsch, A. B., T. P. Shanley, V. Sarma, and P. A. Ward. 1997. In vivo suppression of NF-kappa B and preservation of I kappa B alpha by interleukin-10 and interleukin-13. J. Clin. Invest. 100: 2443-2448.
31. Fan, J., R. D. Ye, and A. B. Malik. 2001. Transcriptional mechanisms of acute lung injury. Am. J. Physiol. Lung Cell. Mol. Physiol. 281: L1037-L1050.
32. Rahman, I., and W. MacNee. 1998. Role of transcription factors in inflammatory lung diseases. Thorax 53: 601-612.
33. Gao, H., R. F. Guo, C. L. Speyer, J. Reuben, T. A. Neff, L. M. Hoesel, N. C. Riedemann, S. D. McClintock, J. V. Sarma, N. Van Rooijen, et al. 2004. Stat3 activation in acute lung injury. J. Immunol. 172: 7703-7712.
34. Yan, C., M. Zhu, J. Staiger, P. F. Johnson, and H. Gao. 2012. C5a-regulated CCAAT/enhancer-binding proteins β and δ are essential in Fcγ receptor-mediated inflammatory cytokine and chemokine production in macrophages. J. Biol. Chem. 287: 3217-3230.
35. Shanley, T. P., H. Schmal, R. L. Warner, E. Schmid, H. P. Friedl, and P. A. Ward. 1997. Requirement for C-X-C chemokines (macrophage inflammatory protein-2 and cytokine-induced neutrophil chemoattractant) in IgG immune complex-induced lung injury. J. Immunol. 158: 3439-3448.
36. Shanley, T. P., H. Schmal, H. P. Friedl, M. L. Jones, and P. A. Ward. 1995. Role of macrophage inflammatory protein-1 alpha (MIP-1 alpha) in acute lung injury in rats. J. Immunol. 154: 4793-4802.
37. Bless, N. M., M. Huber-Lang, R. F. Guo, R. L. Warner, H. Schmal, B. J. Czermak, T. P. Shanley, L. D. Crouch, A. B. Lentsch, V. Sarma, et al. 2000. Role of CC chemokines (macrophage inflammatory protein-1 beta, monocyte chemoattractant protein-1, RANTES) in acute lung injury in rats. J. Immunol. 164: 2650-2659.
38. Mulligan, M. S., A. A. Vaporciyan, M. Miyasaka, T. Tamatani, and P. A. Ward. 1993. Tumor necrosis factor alpha regulates in vivo intrapulmonary expression of ICAM-1. Am. J. Pathol. 142: 1739-1749.
39. Kaminska, B., B. Pyrzynska, I. Ciechomska, and M. Wisniewska. 2000. Modulation of the composition of AP-1 complex and its impact on transcriptional activity. Acta Neurobiol. Exp. 60: 395-402.
40. Tanaka, T., S. Akira, K. Yoshida, M. Umemoto, Y. Yoneda, N. Shirafuji, H. Fujiwara, S. Suematsu, N. Yoshida, and T. Kishimoto. 1995. Targeted disruption of the NF-IL6 gene discloses its essential role in bacteria killing and tumor cytotoxicity by macrophages. Cell 80: 353-361.
41. Uematsu, S., T. Kaisho, T. Tanaka, M. Matsumoto, M. Yamakami, H. Omori, M. Yamamoto, T. Yoshimori, and S. Akira. 2007. The C/EBP beta isoform 34- kDa LAP is responsible for NF-IL-6-mediated gene induction in activated macrophages, but is not essential for intracellular bacteria killing. J. Immunol. 179: 5378-5386.
42. Matsumoto, M., T. Tanaka, T. Kaisho, H. Sanjo, N. G. Copeland, D. J. Gilbert, N. A. Jenkins, and S. Akira. 1999. A novel LPS-inducible C-type lectin is a transcriptional target of NF-IL6 in macrophages. J. Immunol. 163: 5039-5048.
43. Lu, Y. C., I. Kim, E. Lye, F. Shen, N. Suzuki, S. Suzuki, S. Gerondakis, S. Akira, S. L. Gaffen, W. C. Yeh, and P. S. Ohashi. 2009. Differential role for c-Rel and C/EBPbeta/delta in TLR-mediated induction of proinflammatory cytokines. J. Immunol. 182: 7212-7221.